Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-101501

Chief Business Officer sold 3,101 shares at $35.71 ($110,737)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2024-08-26 Sale −3,101 $35.71 $110,737 23,190 D
Open-market sales · 3,101 sh · avg $35.71 · $110,737
Loading xslF345X05/ownership.xml…